AR Asset Management’s GSK GSK Stock Holding History

AR Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,080	Closed	-$484K	–	112
2015 Q3	$484K	Hold	10,080	–	–	0.22%	91
2015 Q2	$525K	Buy	+10,080	New	+$568K	0.21%	85

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AR Asset Management's GSK Position: Q4 2015 in Review

AR Asset Management sold out of GSK (GSK) in Q4 2015, closing a stake of 10,080 shares — an estimated $484K sold.

AR Asset Management first reported a position in GSK in Q2 2015 and held it in 2 quarters. The position peaked at $525K in Q2 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

AR Asset Management reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
AR Asset Management sold 10,080 GSK shares in Q4 2015, an estimated $484K.
AR Asset Management first reported a position in GSK in Q2 2015 and held it in 2 quarters.
AR Asset Management's GSK position peaked at $525K in Q2 2015.
719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on AR Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.